Clinical Trial Update: Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring green tea extract for Stage I and Stage II prostate cancer has been terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: Sanjay Gupta PhD | Conditions: Stage I Prostate Cancer, Stage IIA Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-03-03